Abstract
Intuitive Surgical Inc.’s da Vinci Surgical System is a leading robotic technology in the global market today. Approved by the FDA in 2000, it can be used in cardiac, thoracic, colorectal, general, head and neck, gynecology and urology surgeries. It took several years for Tianjin University, based in China, to develop a minimally invasive surgical robot system called the Micro Hand S. From 2014 to 2015, the system went through human clinical trials, operating on patients in need of laparoscopic surgery. With positive results and no technical problems or complications encountered, the Micro Hand S has the potential to be a safe and effective system for surgeries in the future. Surgeons in China are required to go through extensive training before they are able to use the surgical robot in operations. Hong Kong is a leading location in Asia where many robotic surgeries have been performed. In 2012, Hong Kong acquired the first Robotic Interactive Orthopedic (RIO) system in Asia from MAKO Surgical Corporation (acquired by Stryker Corp.). The RIO system is mainly used for partial knee replacement surgeries, but can potentially be used for hip, ligament, and spinal surgeries as well. The RIO system enables the surgeon to hold and guide the robotic arm during the surgery, rather than operate it remotely on a console. Not only can surgeons perform more difficult surgeries with the RIO system, but they can also sometimes do it with less experience.
Taiwan has the most surgical robots in Asia relative to its population. While there are benefits to robotic surgery as discussed earlier, many hospitals in Taiwan are being criticized for recommending expensive robot-assisted surgeries when traditional surgeries would have sufficed. In Japan, the government is currently collaborating with five universities and 14 companies to develop a robotic surgery system that allows doctors to operate with more precision and accuracy, as well as simultaneously monitor MRI readings and data from other devices. In 2015, Japanese researchers revealed EMARO, an air-powered endoscopic robot that gives surgeons hands-free control and enhances visualization inside a patient’s body with three movable cameras. It is expected to be marketed to hospitals and universities in Japan in the fall of 2016 and be available overseas within the next few years. Like many other Asian countries, Korea is adapting surgical robots for healthcare, too. Robotic surgery training is not required in Korea and has sometimes led to adverse events that possibly could have been avoided. A training center was therefore opened in 2008 at a Korean hospital for surgeons to gain experience and practice the skills necessary to operate surgical robots. Inspired by the renowned da Vinci system, the Meere Company in Korea has been developing the new Revo-i system since 2007. Revo-i is a robot for laparoscopic surgeries that will be used to treat cancer. It is undergoing human testing this year and is estimated to cost a third of the price of the da Vinci system.
Biography
Dr. Koon Ho Rha is Professor of Urology and Robotic and Minimally Invasive Surgery Center. He received both his premedicine education magna cum laude and his M.D. degree from the Yonsei University, Seoul. Dr. Rha was trained during his urological rotating residency training at the Mayo Clinic in Minnesota. He underwent fellowship training in minimally invasive and laparoscopic surgery at the Johns Hopkins Medical Institution as Engineering and Urology endowed fellow, and served as visiting Assistant Professor in Urology at the Johns Hopkins University School of Medicine. During his stay, he also completed “Business in Medicine” a 1-year MBA program at the School of Business Administration and Education.
Prior to his return to Yonsei in 2003, Dr. Rha obtained extensive experience in minimally invasive and laparoscopic surgery at Yonsei University and co-invented a novel surgical procedure “Video-Assisted Minilaparotomy Surgery (VAMS)”, which is now commercially available through Thompson Surgical, Inc. Later at Johns Hopkins, he continued his interests in the field of minimally invasive surgery/laparoscopy, and conducted further scientific studies with Dr. Louis R. Kavoussi, the leading pioneer on laparoscopic and robotic surgery. Dr. Rha set up the robotic surgery program at Yonsei University in 2005 which now became the most successful robotic program in the world with more than 21,000 cases. During last 10 years, Dr. Rha has performed the most robotic urological cases in Asia with more than 3000 cases of robotic cases including some 2500 cases of robotic prostatectomies. With cumulative experiences, Dr. Rha’s team developed world’s first robotic approaches of nephroureterectomies and single-incision partial nephrectomies. He has given more than 500 lectures on robotic surgery. He also performed live surgery or proctored more than 60 occasions, including US, France, Italy, Czech Republic, China, Japan, Taiwan, Singapore, Hong Kong, Saudi Arabia, Thailand and Malaysia. With interest in developing surgical robotic platform and devices, Dr. Rha lead the development Korean surgical (Revo-I, MeereCompany) since 2007 and successfully finished first human trial on robotic prostatectomy in 2017.
Dr. Rha has more than 280 peer-reviewed scientific publications on minimally invasive urological surgery. He is the Immediate Past-President of Korean Endourological Society served as past president of Engineering and Urology Society and member of the American Urological Association, American College of Surgeons, Endourological Society, and Society of Laparoendoscopic Surgeons. Dr. Rha will host Video Urology and East Asia Endourology Conference in June 2019 in Seoul.
CURRICULUM VITAE : Koon Ho RHA, M.D., FACS, Ph.D.
EDUCATION
2016 Harvard School of Public Health “Healthcare Executives Leadership Strategies”
2015 Yonsei University School of Public Health “Globalization of Healthcare”
2010 Harvard School of Public Health “Leadership in Academic Medicine”
2002-2003 Johns Hopkins University, School of Business/Medicine
: “Business in Medicine” Certificate Program”, Baltimore, MD, USA
(courses in managed care, accounting, health care finance, and leadership)
1993-1999 Yonsei University, Graduate School, Seoul, Korea; PhD
1988-1992 Yonsei University, Seoul, Korea; MD (Graduated with Honors)
1980-1984 South Pasadena High School, South Pasadena, CA, USA
POSTDOCTORAL TRAINING
2002-2003 Society for Urology and Engineering Fellow
Johns Hopkins Hospital, Baltimore, Maryland, USA
1995 Visiting Resident; Urology, Mayo Clinic, Rochester, Minnesota, USA
1993-1997 Resident, Urology, Severance Hospital, Yonsei University, Seoul, Korea
HOSPITAL/ACADEMIC APPOINTMENTS
2016.11- present : Chief Strategy Officer, Yonsei University Health System
2014.9. – 2016.8 : Chief Operating Officer, Severance Hospital, Yonsei University
2012.9 – 2014.8 : Associate Dean, Academic Affairs, Yonsei University
2002.4. – present: Professor; Department of Urology, Yonsei University
1998 - present: Consultant in Urology, 121 General Hospital; US Army, Seoul, Korea
2002 - 2003 Faculty (Visiting Assistant Professor); Johns Hopkins University, USA
2000 - 2002.3.: Instructor in Urology, Yonsei University, College of Medicine
1998 - 2000: Urologist in Chief, Capital Armed Forced Hospital, Seoul, Korea
CERTIFICATION AND LICENSURE
2003 DaVinci Certification 2003 Zeus Certification
1997 Korean Board of Urology (#1108)
1992 ECFGM Certification (#0-457-651-8)
PATENTS
Rha KH and Yang SC. (2002), “Surgical instruments and method for creating anatomic working space in minilaparotomy procedure”, US Patent No. 6,878,110
MEMBERSHIP IN PROFESSIONAL SOCIETIES
Fellow, American College of Surgeons (FACS)
Past President, Engineering and Urology Society, USA
Associate Editor, KJU, J Endourology, BJU Int, J Robotic Surgery
Expert, International Healthcare Subject Matter Experts (US Department of Army)
SCI PEER-REVIEWED SCI PUBLICATIONS (300)
CLINCIAL EXPERIENCE : 3000 robotic cases (2500 prostatectomies)
Live Surgery/Proctorship in 14 different countries including USA, France, Italy
First Korean Robot (REVO-i) Prostatectomy (2016.9)